Home Page |
References | OMIM | Gene | GeneReviews | HGMD | HGNC |
GENATLAS PHENOTYPE |
last update : 05-12-2012 |
Symbol | DEL9Q22 |
Location | 9q22.31 |
Name | chromosome 9q22.3 microdeletion syndrome |
Corresponding gene | PTCH1 , ROR2 , FANCC |
Main clinical features |
|
Genetic determination | chromosomal |
Related entries | NBCCS |
Function/system disorder | multisystem/generalized |
mental retardation | |
neoplasia | |
Type | MCA/MR |
Gene product |
Name | numerous genes deleted |
Mechanism(s) |
Gene mutation | Chromosome rearrangement | Effect | Comments |
|  
| deletion
| haploinsufficiency
| very variable size with an overlapping region of 5mb between 92.7 and 97.7Mb including both ROR2 and PTCH
|  
| deletion
| haploinsufficiency
| The minimal critical region is 352 kb, and includes PTCH1 and FANCC.PMID: 21850767
| |
Remark(s) | deletions encompass numerous genes, including PTCH causative for Gorlin syndrome and ROR2, a cell surface receptor, whose mutations are responsible for Robinow syndrome and brachydactyly type 1B ; familial 9q22.3 microduplication spanning PTCH1 causes short stature syndrome with mild intellectual disability and dysmorphic features PMID: 21567912 . PMID: 21850767 ; these were a 929kb region for metopic craniosynostosis, a 1.08Mb region for obstructive hydrocephalus, and a 1.84Mb region for macrosomia, PMID: 22190277;; |
Genotype/Phenotype correlations | early recognition of BCNS is important to prevent neoplasia ; overgrowth and loss of paternal allele in 5/23 patients having a 9q22 deletion ; patients with constitutional 9q22.3 microdeletion have an increased risk of WT, PTCH1 may have a role in the pathogenesis of nephroblastomas,PMID:23169491.. |